Advances in targeted therapies for hepatocellular carcinoma in the genomic era
Advances in targeted therapies for hepatocellular carcinoma in the genomic era. form Tiotropium Bromide colonies at low cell density. Conclusion: Resminostat shifts mesenchymal cells towards a more epithelial phenotype, lower…